Literature DB >> 21601459

To repress or not to repress: this is the guardian's question.

John L Rinn1, Maite Huarte.   

Abstract

p53 is possibly the most central tumor suppressor gene of our cells, integrating stress signals to activate a transcriptional program responsible for maintaining cellular homeostasis. Many of the downstream effects of p53 are a consequence of its activity as a transcription factor, resulting in the induction of multiple target genes. In addition to gene activation, however, gene repression is an essential part of the p53 cellular response. Despite extensive research efforts towards the elucidation of p53 functions, the molecular mechanisms and biological consequences of gene repression by p53 have not been studied extensively. We review our current knowledge of the mechanisms and biological consequences of p53 repression, with special attention to recently discovered mechanisms of repression that involve non-coding RNA molecules, an emerging aspect of regulation in the p53 cellular network.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21601459     DOI: 10.1016/j.tcb.2011.04.002

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  37 in total

Review 1.  Genome regulation by long noncoding RNAs.

Authors:  John L Rinn; Howard Y Chang
Journal:  Annu Rev Biochem       Date:  2012       Impact factor: 23.643

2.  Uncovering the role of genomic "dark matter" in human disease.

Authors:  Lance Martin; Howard Y Chang
Journal:  J Clin Invest       Date:  2012-05-01       Impact factor: 14.808

Review 3.  Non-coding RNAs in Saccharomyces cerevisiae: what is the function?

Authors:  Jian Wu; Daniela Delneri; Raymond T O'Keefe
Journal:  Biochem Soc Trans       Date:  2012-08       Impact factor: 5.407

4.  p53 Loses grip on PIK3CA expression leading to enhanced cell survival during platinum resistance.

Authors:  Bhushan Thakur; Pritha Ray
Journal:  Mol Oncol       Date:  2016-06-29       Impact factor: 6.603

5.  6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.

Authors:  S Ros; J Flöter; I Kaymak; C Da Costa; A Houddane; S Dubuis; B Griffiths; R Mitter; S Walz; S Blake; A Behrens; K M Brindle; N Zamboni; M H Rider; A Schulze
Journal:  Oncogene       Date:  2017-01-16       Impact factor: 9.867

6.  Activation of p53 transcriptional activity by SMRT: a histone deacetylase 3-independent function of a transcriptional corepressor.

Authors:  Anbu Karani Adikesavan; Sudipan Karmakar; Patricia Pardo; Liguo Wang; Shuang Liu; Wei Li; Carolyn L Smith
Journal:  Mol Cell Biol       Date:  2014-01-21       Impact factor: 4.272

Review 7.  Mutant TP53 posttranslational modifications: challenges and opportunities.

Authors:  Thuy-Ai Nguyen; Daniel Menendez; Michael A Resnick; Carl W Anderson
Journal:  Hum Mutat       Date:  2014-02-11       Impact factor: 4.878

8.  Distinct p53 genomic binding patterns in normal and cancer-derived human cells.

Authors:  Krassimira Botcheva; Sean R McCorkle; W R McCombie; John J Dunn; Carl W Anderson
Journal:  Cell Cycle       Date:  2011-12-15       Impact factor: 4.534

9.  CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress.

Authors:  Baharan Fekry; Kristen A Jeffries; Amin Esmaeilniakooshkghazi; Besim Ogretmen; Sergey A Krupenko; Natalia I Krupenko
Journal:  J Biol Chem       Date:  2016-06-14       Impact factor: 5.157

Review 10.  MicroRNAs in the p53 network: micromanagement of tumour suppression.

Authors:  Heiko Hermeking
Journal:  Nat Rev Cancer       Date:  2012-08-17       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.